abstract |
The present invention relates to substituted pyrazoloquinolines of formula I and their derivatives, the use of these compounds as phosphodiesterase 10 (PDE10) inhibitors for treating PDE10 dysregulation, pharmaceutical compositions comprising these compounds, and PDE10 It relates to the use of further substituted pyrazoloquinolines and their derivatives for treating dysregulation. |